Breast cancer: Biology, biomarkers, and treatments

K Barzaman, J Karami, Z Zarei, A Hosseinzadeh… - International …, 2020‏ - Elsevier
During the past recent years, various therapies emerged in the era of breast cancer. Breast
cancer is a heterogeneous disease in which genetic and environmental factors are involved …

[HTML][HTML] Application of dendrimers in anticancer diagnostics and therapy

Z Bober, D Bartusik-Aebisher, D Aebisher - Molecules, 2022‏ - mdpi.com
The application of dendrimeric constructs in medical diagnostics and therapeutics is
increasing. Dendrimers have attracted attention due to their compact, spherical three …

Nanoparticles-based drug delivery and gene therapy for breast cancer: Recent advancements and future challenges

Z Mirza, S Karim - Seminars in cancer biology, 2021‏ - Elsevier
Breast cancer (BC) is amongst the most lethal cancer among females and conventional
treatment methods like surgery, radiotherapy and chemotherapy are not effective enough as …

Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer

N Rajana, A Mounika, PS Chary, V Bhavana… - Journal of Controlled …, 2022‏ - Elsevier
Breast cancer is the most prevalent non-cutaneous malignancy in women, with greater than
a million new cases every year. In the last decennium, numerous diagnostic and treatment …

[HTML][HTML] Drug uptake-based chemoresistance in breast cancer treatment

H Muley, R Fado, R Rodriguez-Rodriguez… - Biochemical …, 2020‏ - Elsevier
Breast cancer is the most prevalent type of tumor and the second leading cause of death
due to cancer among women. Although screening methods, diagnosis and therapeutic …

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies

F Yang, Q He, X Dai, X Zhang, D Song - Frontiers in pharmacology, 2023‏ - frontiersin.org
Breast cancer (BC) is the most frequently diagnosed malignant tumor among women in the
world. BC is the heterogeneous tumor with different subtypes including luminal A-like …

Breast cancer drug delivery by novel drug-loaded chitosan-coated magnetic nanoparticles

A Taherian, N Esfandiari, S Rouhani - Cancer Nanotechnology, 2021‏ - Springer
Background Breast cancer is one of the most challenging cancers among women which is
considered one of the most lethal cancers to this date. From the time that cancer has been …

Quercetin against MCF7 and CAL51 breast cancer cell lines: apoptosis, gene expression and cytotoxicity of nano-quercetin

HA Mohammed, GM Sulaiman, SS Anwar… - …, 2021‏ - Taylor & Francis
Aims: To evaluate the anti breast-cancer activity, biocompatibility and toxicity of poly (d, l)-
lactic-co-glycolic acid (PLGA)-encapsulated quercetin nanoparticles (Q-PLGA-NPs) …

Clinical therapies and nano drug delivery systems for urinary bladder cancer

P Jain, H Kathuria, M Momin - Pharmacology & Therapeutics, 2021‏ - Elsevier
Bladder cancer is the 10 th most commonly occurring malignancy worldwide with a 75% of 5-
year survival rate, while it ranks 13 th among the deaths occurring due to cancer. The …

[HTML][HTML] Antibody conjugation of nanoparticles as therapeutics for breast cancer treatment

A Juan, FJ Cimas, I Bravo, A Pandiella… - International journal of …, 2020‏ - mdpi.com
Breast cancer is the most common invasive tumor in women and the second leading cause
of cancer-related death. Nanomedicine raises high expectations for millions of patients as it …